儿童常见后天性冠状动脉病变诊治进展
Progress in the Diagnosis and Treatment of Common Acquired Coronary Artery Lesions in Children
DOI: 10.12677/ACM.2022.125572, PDF,   
作者: 范文涛, 易岂建：重庆医科大学附属儿童医院心血管内科，国家儿童健康与疾病临床医学研究中心，重庆
关键词: 儿童；后天性；冠状动脉病变；诊断；治疗；Children； Acquired； Coronary Artery Lesions； Diagnosis； Treatment
摘要: 儿童冠状动脉病变表现为冠状动脉扩张、狭窄、闭塞，可引起急性冠脉综合征、慢性心肌缺血。病因包含多种先天性和后天性疾病，后天性病因主要包括川崎病、儿童多系统炎症综合征、多发性大动脉炎、支原体及EB病毒感染等，现就引起儿童冠状动脉病变的常见后天性疾病的病因、机制、临床表现、诊治等做出综述，以提高认识、早期诊断和治疗，预防儿童冠状动脉病变发生或延缓其进展。
Abstract: Coronary artery disease in children manifests as coronary dilatation, stenosis, and occlusion, which can cause acute coronary syndrome and chronic myocardial ischemia. The etiology includes a vari-ety of congenital and acquired diseases, and the acquired causes mainly include Kawasaki disease, multisystem inflammatory syndrome in children, Takayasu’s arteritis, mycoplasma and Ep-stein-Barrvirus infection. The etiology, mechanism, clinical manifestations, diagnosis and treatment of common acquired diseases causing coronary artery disease in children are reviewed to improve awareness, early diagnosis and treatment, and prevent the occurrence of coronary artery disease in children.
文章引用：范文涛, 易岂建. 儿童常见后天性冠状动脉病变诊治进展[J]. 临床医学进展, 2022, 12(5): 3944-3949. https://doi.org/10.12677/ACM.2022.125572

参考文献

[1] 安琪, 李守军. 先天性心脏病外科治疗中国专家共识(十二): 先天性冠状动脉异常[J]. 中国胸心血管外科临床杂志, 2020, 27(12): 1375-1381.
[2] Lu, Y., Guo, Y., Si, F., et al. (2020) Predictive Value of Heart Rate Deceleration Capacity on Coronary Artery Lesion in Acute Phase of Kawasaki Disease. Scientific Reports, 10, Article No. 10211. [Google Scholar] [CrossRef] [PubMed]
[3] Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. and Theocharis, P. (2020) Hyperinflammatory Shock in Children during COVID-19 Pandemic. The Lancet, 395, 1607-1608. [Google Scholar] [CrossRef] 
[4] Kabeerdoss, J., Pilania, R.K., Karkhele, R., Kumar, T.S., Danda, D. and Singh, S. (2021) Severe COVID-19, Multisystem Inflammatory Syndrome in Children, and Kawasaki Disease: Immunological Mechanisms, Clinical Manifestations and Management. Rheumatology International, 41, 19-32. [Google Scholar] [CrossRef] [PubMed]
[5] Lei, C., Huang, Y., Yuan, S., et al. (2020) Takayasu Arteritis with Coronary Artery Involvement: Differences between Pediatric and Adult Patients. Canadian Journal of Cardiology, 36, 535-542. [Google Scholar] [CrossRef] [PubMed]
[6] Eleftheriou, D., Varnier, G., Dolezalova, P., McMahon, A.M., Al-Obaidi, M. and Brogan, P.A. (2015) Takayasu Arteritis in Childhood: Retrospective Experience from a Tertiary Referral Centre in the United Kingdom. Arthritis Research & Therapy, 17, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[7] Gao, L.W., Yin, J., Hu, Y.H., et al. (2019) The Epidemiology of Paediatric Mycoplasma pneumoniae Pneumonia in North China: 2006 to 2016. Epidemiology & Infection, 147, E192. [Google Scholar] [CrossRef] 
[8] Chen, P., Huang, Z., Chen, L., et al. (2021) The Relationships between LncRNA NNT-AS1, CRP, PCT and Their Interactions and the Refractory Mycoplasma pneumoniae Pneumonia in Children. Scientific Reports, 11, Article No. 2059. [Google Scholar] [CrossRef] [PubMed]
[9] 刘京晶, 郑春华, 李晓惠等. 传染性单核细胞增多症伴冠状动脉扩张病例分析[J]. 中国医药导报, 2017, 14(29): 76-79.
[10] 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会. 川崎病冠状动脉病变的临床处理建议(2020年修订版) [J]. 中华儿科杂志, 2020, 58(9): 718-724.
[11] Tangye, S.G., Palendira, U. and Edwards, E.S. (2017) Human Immunity against EBV-Lessons from the Clinic. Journal of Experimental Medicine, 214, 269-283. [Google Scholar] [CrossRef] [PubMed]
[12] Yang, M., Meng, F., Gao, M., Cheng, G. and Wang, X. (2019) Cyto-kine Signatures Associate with Disease Severity in Children with Mycoplasma pneumoniae Pneumonia. Scientific Re-ports, 9, Article No. 17853. [Google Scholar] [CrossRef] [PubMed]
[13] Matsubara, K. and Fukaya, T. (2007) The Role of Superantigens of Group A Streptococcus and Staphylococcus aureus in Kawasaki Disease. Current Opinion in Infectious Diseases, 20, 298-303. [Google Scholar] [CrossRef] 
[14] Korematsu, S., Ohta, Y., Tamai, N., et al. (2012) Cell Dis-tribution Differences of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Kawasaki Disease. The Pediatric Infectious Disease Journal, 31, 973-974. [Google Scholar] [CrossRef] 
[15] Whittaker, E., Bamford, A., Kenny, J., et al. (2020) Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. Journal of the American Medical Association, 324, 259-269. [Google Scholar] [CrossRef] [PubMed]
[16] Nakra, N.A., Blumberg, D.A., Herrera-Guerra, A. and Lakshmin-rusimha, S. (2020) Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Re-view of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children, 7, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[17] 李楠, 张久山. 多发性大动脉炎的临床治疗进展[J]. 中国心血管杂志, 2006, 11(3): 226-228.
[18] 王全, 蒋健飞, 赵德育. 肺炎支原体肺炎发生肺外并发症的危险因素[J]. 中华实用儿科临床杂志, 2013, 28(10): 749-751.
[19] Binkley, P.F., Cooke, G.E., Lesinski, A., et al. (2013) Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events. PLoS ONE, 8, e54008. [Google Scholar] [CrossRef] [PubMed]
[20] McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Profession-als from the American Heart Association. Circulation, 135, e927-e999. [Google Scholar] [CrossRef] 
[21] Kobayashi, T., Ayusawa, M., Suzuki, H., et al. (2020) Re-vision of Diagnostic Guidelines for Kawasaki Disease (6th Revised Edition). Pediatrics International, 62, 1135-1138. [Google Scholar] [CrossRef] [PubMed]
[22] 李金玲, 骆盼, 司朝辉. 支原体感染对川崎病患儿血清炎症因子水平及冠状动脉损害的影响[J]. 川北医学院学报, 2020, 35(1): 69-72.
[23] Tang, Y., Gao, X., Shen, J., Sun, L. and Yan, W. (2016) Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Ar-tery Abnormalities in East China: Nine Years Experience. Journal of Tropical Pediatrics, 62, 86-93. [Google Scholar] [CrossRef] [PubMed]
[24] 时艳艳, 刘芳, 吴琳, 马晓静, 梁雪村, 黄国英. 川崎病冠状动脉病变严重程度临床分级及高危因素研究[J]. 中国实用儿科杂志, 2014, 29(9): 681-686.
[25] Chuang, H.C., Lay, J.D., Hsieh, W.C., et al. (2005) Epstein-Barr Virus LMP1 Inhibits the Expression of SAP Gene and Upregulates Th1 Cytokines in the Pathogenesis of Hemophagocytic Syndrome. Blood, 106, 3090-3096. [Google Scholar] [CrossRef] [PubMed]
[26] Henderson, L.A., Canna, S.W., Friedman, K.G., et al. (2022) American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis & Rheumatology, 74, e1-e20. [Google Scholar] [CrossRef] [PubMed]
[27] Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. (2020) Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from Simultaneous familial Kawasaki Disease Cases. International Journal of Infectious Diseases, 97, 371-373. [Google Scholar] [CrossRef] [PubMed]
[28] Godfred-Cato, S., Bryant, B., Leung, J., et al. (2020) COVID-19-Associated Multisystem Inflammatory Syndrome in Children—United States, March-July 2020. Morbidity and Mortality Weekly Report, 69, 1074-1080. [Google Scholar] [CrossRef] [PubMed]
[29] de Graeff, N., Groot, N., Brogan, P., et al. (2019) European Consensus-Based Recommendations for the Diagnosis and Treatment of Rare Paediatric Vasculitides—The SHARE Ini-tiative. Rheumatology, 58, 656-671. [Google Scholar] [CrossRef] [PubMed]
[30] Maksimowicz-McKinnon, K., Clark, T.M. and Hoffman, G.S. (2014) Limitations of Therapy and a Guarded Prognosis in an American Cohort of Takayasu arteritis Patients. Arthritis & Rheumatism, 56, 1000-1009. [Google Scholar] [CrossRef] [PubMed]
[31] 朱美华, 梁敏, 王志坚, 温红艳. 抗病毒治疗对儿童传染性单核细胞增多症的价值探讨[J]. 中国当代儿科杂志, 2012, 14(3): 198-201.

为你推荐